The short version
- "Superfood" is a marketing term, not a scientific category. I eat them, but I only trust the ones with human data.
- The strongest evidence is for whole dietary patterns: a Mediterranean diet with extra-virgin olive oil or nuts cut major cardiovascular events in a large randomized trial1.
- Most of the rest is observational (leafy greens, nuts) or small and short (broccoli sprouts, berries, fermented foods), or came back mixed (cocoa, avocado).
- Most of this list fits a keto diet. Berries need a carb budget, and cocoa trial results came from a flavanol extract, not candy2.
- Nothing here is a magic bullet; each result comes with limits I list below.
The protocol
What the studies actually used, not what I do:
| Food | Amount used in the research | Keto-friendly? |
|---|---|---|
| Broccoli sprouts | A daily beverage with 600 micromol glucoraphanin and 40 micromol sulforaphane for 12 weeks3 | Yes |
| Fatty fish | One to two seafood meals a week (AHA advisory)4 | Yes |
| Extra-virgin olive oil | As part of a Mediterranean diet in PREDIMED1 | Yes |
| Leafy greens | About 1.3 servings a day in the top intake group5 | Yes |
| Blueberries | 75 g or 150 g a day for 6 months; only 150 g moved anything6 | Depends on your carb limit |
| Fermented foods | A high-fermented-food diet for 17 weeks7 | Depends on the food |
| Nuts | 28 g a day in the meta-analysis8 | Mostly, in moderation |
| Avocado | One a day for 6 months9 | Yes |
| Cocoa flavanols | 500 mg flavanols a day, including 80 mg epicatechin, as an extract2 | The extract, yes; chocolate depends on its sugar |
Why it works
The proposed mechanisms are specific compounds: sulforaphane from broccoli sprouts acting through the NRF2 pathway10, anthocyanin-derived signaling compounds from blueberries11, and flavanols from cocoa2. Much of that mechanism work is in cells and animals10, so I lean on the human trials below, which test outcomes, and treat the mechanisms as hypotheses.
What the research says
Broccoli sprouts and sulforaphane
Early In a placebo-controlled trial of 291 adults in rural China, a daily broccoli sprout beverage for 12 weeks raised urinary excretion of the air pollutant benzene (61%) and acrolein (23%) compared with placebo; crotonaldehyde did not change3. That is a biomarker of detoxification, not a measure of illness3. In type 2 diabetes, a Science Translational Medicine paper found sulforaphane suppressed glucose production through the NRF2 pathway in cells and animals and, in obese patients with dysregulated type 2 diabetes, a concentrated broccoli sprout extract reduced fasting glucose and HbA1c10. The abstract gives no sample size or numbers for the human part, and much of the work is in cells and animals10.
Fatty fish
Moderate The American Heart Association advisory recommends one to two seafood meals a week to lower the risk of heart failure, coronary heart disease, ischemic stroke, and sudden cardiac death, with the biggest benefit when seafood replaces less healthy foods4. The advisory leans heavily on observational studies, and the trials of omega-3 pills are mixed, which I cover on the heart page.
Extra virgin olive oil
Moderate PREDIMED randomized 7,447 Spanish adults aged 55 to 80 at high cardiovascular risk to a Mediterranean diet with extra-virgin olive oil, a Mediterranean diet with nuts, or a low-fat control diet. Over a median 4.8 years, major cardiovascular events had HR 0.69 (95% CI 0.53 to 0.91) with olive oil and 0.72 (0.54 to 0.95) with nuts1. The original 2013 report was withdrawn after protocol deviations in randomization at some sites, and this 2018 republication re-analyzed the data1. It tests a whole eating pattern, not olive oil alone.
Leafy greens
Moderate In 960 older adults followed a mean 4.7 years, the top fifth of green leafy vegetable intake (median 1.3 servings a day) declined more slowly on cognitive tests, a gap the authors equated to being 11 years younger5. It is observational, so I read it as a consistent signal, not proof.
Berries
Early In 115 adults with metabolic syndrome, 150 g of blueberries a day for 6 months improved flow-mediated dilatation by 1.45% and augmentation index by 2.24%, while insulin resistance (the primary endpoint), blood pressure, and pulse wave velocity did not change; 75 g a day did nothing6. Rhonda Patrick's blueberry episode argues that anthocyanin-derived signaling compounds, not antioxidant effects, may explain the vascular benefits11.
Fermented foods
Early A 17-week randomized trial of healthy adults (18 per arm) found a high-fermented-food diet steadily increased microbiome diversity and decreased inflammatory markers, while a high-fiber diet left diversity stable and the primary outcome, the cytokine response score, unchanged7. It is small, and several authors declared financial interests in microbiome companies7.
Nuts
Moderate A dose-response meta-analysis of 20 prospective studies found each 28 g a day of nuts was linked to lower cardiovascular disease (RR 0.79, 95% CI 0.70 to 0.88), coronary heart disease (RR 0.71), and all-cause mortality (RR 0.78)8. These are observational. In PREDIMED, the nut arm also had fewer cardiovascular events than control (HR 0.72)1.
Avocado
Mixed In the Hass Avocado Trial, 1,008 adults with a large waist ate one avocado a day or their usual diet for 6 months. Visceral fat did not change (difference 0.017 L, 95% CI -0.024 to 0.058), and LDL cholesterol showed a modest, nominally significant decline in the avocado group9. A null main result and a secondary LDL finding is not strong evidence.
Cocoa flavanols
Mixed COSMOS randomized 21,442 older adults to 500 mg a day of cocoa flavanols or placebo. Total cardiovascular events were not significantly lower (HR 0.90, 95% CI 0.78 to 1.02), but cardiovascular death was (HR 0.73, 95% CI 0.54 to 0.98), a secondary outcome over a median 3.6 years2. The trial used a flavanol extract, not chocolate bars2.
Rhonda Patrick on sulforaphane and broccoli sprouts
Sulforaphane is a signature topic on FoundMyFitness. These are conversations and do not mean she endorses this site.
- Jed Fahey, 2017: what sulforaphane is, the NRF2 pathway, whether cooking destroys it in broccoli, supplement quality, gut bacteria, and possible therapeutic uses12.
- Q&A with Jed Fahey, 2020: the minimum effective daily dose, how hard it is to measure sulforaphane in foods, preserving it in cooked food, how often to eat broccoli sprouts and how long the effects last, and safety13.
- Blueberries, 2026: a solo episode on about a cup a day for blood vessel function, brain health, and blood sugar, and a possible polyphenol issue when blueberries are blended with bananas11.
Cautions
- Most findings are associations from observational studies (leafy greens, nuts) or biomarker changes (broccoli sprouts), not proof that the food prevents disease.
- Supplements and extracts are not the same as food: the cocoa trial used a flavanol extract2, and the diabetes trial used a concentrated sprout extract10.
- Eating fish is not the same as taking a high-dose omega-3 drug: in REDUCE-IT, 4 g a day of purified EPA came with more hospitalizations for atrial fibrillation (3.1% versus 2.1%)14.
- On keto, berries, some fermented foods, and sweetened cocoa products depend on your carb limit.
References
- Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. The New England Journal of Medicine. 2018;378(25):e34.Randomized trialPubMed 29897866 · DOI
What it found: PREDIMED, republished in 2018: 7,447 Spanish adults aged 55 to 80 at high cardiovascular risk were assigned a Mediterranean diet with extra-virgin olive oil, a Mediterranean diet with mixed nuts, or a low-fat control diet. Over a median 4.8 years, major cardiovascular events had HR 0.69 (95% CI 0.53 to 0.91) with olive oil and HR 0.72 (0.54 to 0.95) with nuts versus control.
Limits: The original 2013 report was withdrawn after protocol deviations in randomization at some sites, and the trial tests a whole Mediterranean pattern with olive oil or nuts, not olive oil alone.
- Sesso HD, Manson JE, Aragaki AK, Rist PM, Johnson LG, Friedenberg G, et al. Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. The American Journal of Clinical Nutrition. 2022;115(6):1490-1500.Randomized trialPubMed 35294962 · DOI
What it found: COSMOS randomized 21,442 older US adults to 500 mg a day of cocoa flavanols (including 80 mg epicatechin) or placebo; over a median 3.6 years total cardiovascular events had HR 0.90 (95% CI 0.78 to 1.02, not significant), while cardiovascular death had HR 0.73 (0.54 to 0.98) as a secondary outcome.
Limits: The primary outcome missed significance, the death result is secondary, follow-up was short, and the trial used a flavanol extract rather than chocolate.
- Egner PA, Chen JG, Zarth AT, Ng DK, Wang JB, Kensler KH, et al. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. Cancer Prevention Research (Philadelphia, Pa.). 2014;7(8):813-823.Randomized trialPubMed 24913818 · DOI
What it found: Placebo-controlled trial of 291 adults in rural Qidong, China, who drank a daily broccoli sprout beverage (600 micromol glucoraphanin, 40 micromol sulforaphane) or a placebo for 12 weeks. Urinary excretion of benzene mercapturic acid rose 61% and acrolein mercapturic acid 23% versus placebo; crotonaldehyde did not change.
Limits: It measured excretion biomarkers of pollutant exposure, not illness, in one rural region of China.
- Rimm EB, Appel LJ, Chiuve SE, Djoussé L, Engler MB, Kris-Etherton PM, et al. Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association. Circulation. 2018;138(1):e35-e47.Position standPubMed 29773586 · DOI
What it found: AHA science advisory recommending one to two seafood meals a week to reduce the risk of heart failure, coronary heart disease, ischemic stroke, and sudden cardiac death, with the largest benefit when seafood replaces less healthy foods.
Limits: An expert advisory that relies largely on observational studies, and its abstract does not name specific fish or give supplement advice.
- Morris MC, Wang Y, Barnes LL, Bennett DA, Dawson-Hughes B, Booth SL. Nutrients and bioactives in green leafy vegetables and cognitive decline: Prospective study. Neurology. 2018;90(3):e214-e222.Cohort studyPubMed 29263222 · DOI
What it found: Prospective cohort of 960 older adults (aged 58 to 99) followed a mean 4.7 years. Those in the top fifth of green leafy vegetable intake (median 1.3 servings a day) declined more slowly on cognitive tests, a difference the authors equated to being 11 years younger.
Limits: Observational with food questionnaires, so diet cannot be separated from other healthy habits.
- Curtis PJ, van der Velpen V, Berends L, Jennings A, Feelisch M, Umpleby AM, et al. Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome: results from a 6-month, double-blind, randomized controlled trial. The American Journal of Clinical Nutrition. 2019;109(6):1535-1545.Randomized trialPubMed 31136659 · DOI
What it found: Double-blind trial of 115 adults with metabolic syndrome given 75 g or 150 g of blueberries a day or a matched placebo for 6 months. At 150 g, flow-mediated dilatation improved by 1.45% (95% CI 0.83 to 2.1) and augmentation index fell 2.24%; the primary outcome, insulin resistance, did not change, nor did blood pressure, and 75 g had no effect.
Limits: The primary endpoint was null, the benefits were in secondary markers of artery function, and it ran 6 months in people with metabolic syndrome.
- Wastyk HC, Fragiadakis GK, Perelman D, Dahan D, Merrill BD, Yu FB, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137-4153.e14.Randomized trialPubMed 34256014 · DOI
What it found: Randomized 17-week trial in healthy adults (18 per arm) comparing a high-fiber diet with a high-fermented-food diet. The fermented-food diet steadily increased microbiome diversity and decreased inflammatory markers; the high-fiber diet left diversity stable and the primary outcome (cytokine response score) unchanged.
Limits: Only 36 people over 17 weeks, and several authors declared financial interests in microbiome companies.
- Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, et al. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC Medicine. 2016;14(1):207.Meta-analysisPubMed 27916000 · DOI
What it found: Dose-response meta-analysis of 20 prospective studies. Each 28 g (about a handful) of nuts a day was linked to a lower risk of cardiovascular disease (RR 0.79, 95% CI 0.70 to 0.88), coronary heart disease (0.71, 0.63 to 0.80), and all-cause mortality (0.78, 0.72 to 0.84).
Limits: Pooled observational cohorts, so people who eat nuts may differ in other healthy ways.
- Lichtenstein AH, Kris-Etherton PM, Petersen KS, Matthan NR, Barnes S, Vitolins MZ, et al. Effect of Incorporating 1 Avocado Per Day Versus Habitual Diet on Visceral Adiposity: A Randomized Trial. Journal of the American Heart Association. 2022;11(14):e025657.Randomized trialPubMed 35861827 · DOI
What it found: Hass Avocado Trial: 1,008 adults with a large waist were randomized to one avocado a day or their habitual diet for 6 months. Visceral fat did not differ (0.017 L, 95% CI -0.024 to 0.058), while LDL cholesterol showed a modest, nominally significant reduction in the avocado group.
Limits: The main outcome (visceral fat) was null, the LDL result was secondary and the abstract gives no numbers, and I did not verify who funded the trial.
- Axelsson AS, Tubbs E, Mecham B, Chacko S, Nenonen HA, Tang Y, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Science Translational Medicine. 2017;9(394):eaah4477.Randomized trialPubMed 28615356 · DOI
What it found: A drug-signature screen flagged sulforaphane; in liver cells and diabetic animals it suppressed glucose production through NRF2 at a magnitude similar to metformin, and in obese patients with dysregulated type 2 diabetes a concentrated broccoli sprout extract reduced fasting glucose and HbA1c.
Limits: The abstract gives no sample size, dose, or effect sizes for the human arm, and much of the work is in cells and animals.
- Patrick R. #115 The Science of Blueberries for Brain and Vascular Health. FoundMyFitness, October 1, 2026.PodcastListen
What it found: Solo episode arguing that about a cup of blueberries a day may help blood vessel function, brain health, and blood sugar control through signaling compounds made from anthocyanins, and raising the possibility that blending blueberries with bananas reduces polyphenol availability.
Limits: A podcast summary of the research by the host, not a trial; I read only the episode description.
- Patrick R. #029 Jed Fahey, Sc.D. on Isothiocyanates, the Nrf2 Pathway, Moringa & Sulforaphane Supplementation. FoundMyFitness, January 6, 2017.PodcastListen
What it found: Interview with Jed Fahey, a long-time isothiocyanate researcher at Johns Hopkins, on what sulforaphane is, the NRF2 pathway, whether cooking destroys it in broccoli, supplement quality, gut bacteria, and possible therapeutic uses.
Limits: A podcast conversation, not a trial.
- Patrick R. #061 Q&A with Dr. Jed Fahey on Sulforaphane, Moringa and Chemoprotection. FoundMyFitness, November 17, 2020.PodcastListen
What it found: Two-hour listener Q&A with Jed Fahey on sulforaphane: the minimum effective daily dose, how hard it is to measure sulforaphane in foods, preserving it in cooked food, how often to eat broccoli sprouts and how long the effects last, brain glutathione and cancer, supplement alternatives, and safety.
Limits: A podcast conversation, not a trial.
- Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal of Medicine. 2019;380(1):11-22.Randomized trialPubMed 30415628 · DOI
What it found: REDUCE-IT randomized 8,179 statin-treated patients with elevated triglycerides (135 to 499 mg/dL) to 2 g of icosapent ethyl twice daily or placebo for a median 4.9 years. The primary composite endpoint was 17.2% versus 22.0% (HR 0.75, 95% CI 0.68 to 0.83); hospitalization for atrial fibrillation was 3.1% versus 2.1% and serious bleeding 2.7% versus 2.1%.
Limits: Tested a purified prescription EPA drug at 4 g a day in people with high triglycerides on statins, so it does not tell us what over-the-counter fish oil or diet would do.